NFL Biosciences SA

ALNFL

Company Profile

  • Business description

    NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.

  • Contact

    199 rue Helene Boucher
    Castelnau-le-Lez34170
    FRA

    T: +33 411937667

    https://www.nflbiosciences.com/

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    4

Stocks News & Analysis

stocks

Amazon earnings: Good results, with AWS still a winner; fear on profitability guidance is overblown

We think Amazon stock looks attractive.
stocks

Apple earnings: Strong iPhone beat brings our valuation up and tariff costs prove light for now

We think Apple stock looks fairly valued.
stocks

4 ASX shares that could be vulnerable to an August surprise

Any missteps this reporting season could be costly for these shares, which have all risen to lofty valuations.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,900.7016.40-0.18%
CAC 407,546.16225.81-2.91%
DAX 4023,425.97639.50-2.66%
Dow JONES (US)43,588.58542.40-1.23%
FTSE 1009,068.5864.23-0.70%
HKSE24,507.81265.52-1.07%
NASDAQ20,650.13472.31-2.24%
Nikkei 22539,949.12850.48-2.08%
NZX 50 Index12,734.535.130.04%
S&P 5006,238.01101.38-1.60%
S&P/ASX 2008,646.3015.70-0.18%
SSE Composite Index3,559.9513.26-0.37%

Market Movers